atropine has been researched along with biperiden in 27 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (biperiden) | Trials (biperiden) | Recent Studies (post-2010) (biperiden) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 496 | 83 | 79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (48.15) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bhattacharjee, AK; Evans, SA; Gordon, RK; Pervitsky, D; Pomponio, JW | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bill, A; Stjernschantz, J | 1 |
| Eggers, C | 1 |
| Cankaya, A; Gepdiremen, A; Kutlu, N; Tan, U | 1 |
| Carlsson, A; Carlsson, M; Svensson, A | 1 |
| Onodera, K; Shinoda, H | 1 |
| Fischer, E; Heller, B; Lumbreras, N | 1 |
| Jurna, I; Regélhy, B | 1 |
| Jurna, I; Lanzer, G | 1 |
| Bachmann, T; Jurna, I; Theres, C | 1 |
| Boissier, JR; Larousse, C; Simon, P; Villeneuve, A | 1 |
| Jurna, I; Nell, T; Schreyer, I | 1 |
| Boman, K; Meurman, T | 1 |
| Haas, H; Jantos, W | 1 |
| Fincke, M; Gothóni, P; Lehtinen, M | 1 |
| Caviglia, A; Cellitti, M; Di Bianco, V; Di Castro, A; Pavoncello, S | 1 |
| Feibel, H; Levine, J; Schreiber, G; Swartz, M | 1 |
| Kassa, J | 1 |
| Kassa, J; Vachek, J | 1 |
| McDonough, JH; Shih, TM | 1 |
| Fusek, J; Kassa, J | 1 |
1 review(s) available for atropine and biperiden
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for atropine and biperiden
| Article | Year |
|---|---|
Premedication with non-selective and M1-selective muscarinic antagonists before ECT.
Topics: Adult; Aged; Atropine; Biperiden; Depressive Disorder; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Premedication | 1993 |
25 other study(ies) available for atropine and biperiden
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.
Topics: Atropine; Computer Simulation; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Receptor, Muscarinic M1; Structure-Activity Relationship | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effect of intracranial stimulation of the oculomotor nerve on ocular blood flow in the monkey, cat, and rabbit.
Topics: Animals; Atropine; Biperiden; Cats; Choroid; Ciliary Body; Electric Stimulation; Eye; Female; Haplorhini; Iris; Macaca fascicularis; Male; Microspheres; Oculomotor Nerve; Rabbits; Regional Blood Flow; Retinal Vessels; Stereotaxic Techniques | 1979 |
[The acute visual hallucinosis in infancy. Clinical, neurophysiological and psychodevelopmental aspects and differential typology (author's transl)].
Topics: Acute Disease; Age Factors; Atropine; Benzydamine; Biperiden; Cannabis; Child; Child Psychiatry; Child, Preschool; Encephalitis; Female; Fenfluramine; Fever; Hallucinations; Humans; Infant; Male; Measles; Mumps; Poisoning | 1975 |
Parkinsonian-like tremor induced by a combined application of chlorpromazine and pentobarbitone in cats with left-paw preference.
Topics: Animals; Atropine; Baclofen; Biperiden; Cats; Chlorpromazine; Feedback; Female; Functional Laterality; Male; Parkinson Disease, Secondary; Pentobarbital; Tremor | 1992 |
Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
Topics: Adrenergic alpha-Agonists; Animals; Atropine; Biperiden; Clonidine; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Ketamine; Male; Methyldopa; Mice; Mice, Neurologic Mutants; Motor Activity; N-Methylaspartate; Parasympatholytics; Parkinson Disease; Piperazines | 1991 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Influence of anticholinergic-antiparkinsonian agents on the effects of narcoanalgesic drugs in the rat.
Topics: Animals; Antiparkinson Agents; Atropine; Avoidance Learning; Biperiden; Cyclopentanes; Drug Synergism; Drug Tolerance; Ethylamines; Male; Meperidine; Morphine; Parasympatholytics; Phenothiazines; Piperidines; Rats | 1973 |
The antagonism between reserpine and some antiparkinson drugs in electroseizure.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Dextroamphetamine; Dihydroxyphenylalanine; Electroshock; Methamphetamine; Parasympatholytics; Piperidines; Rats; Reserpine; Sympathomimetics; Tachyphylaxis; Tetrabenazine; Thiocarbamates; Tyrosine | 1968 |
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Cyclopentanes; Depression, Chemical; Dihydroxyphenylalanine; Methamphetamine; Motor Activity; Motor Neurons; Movement Disorders; Parasympathomimetics; Phenytoin; Piperidines; Rats; Reserpine; Spinal Cord; Sympathomimetics; Trihexyphenidyl | 1969 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyography; Methamphetamine; Motor Neurons; Movement Disorders; Parasympatholytics; Phenytoin; Physostigmine; Piperidines; Rats; Reserpine; Spinal Cord; Spinal Nerves; Tetrabenazine; Trihexyphenidyl | 1969 |
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Diazepam; Electroshock; Haloperidol; Humans; Imipramine; Iproniazid; Meprobamate; Monoamine Oxidase Inhibitors; Motor Activity; Parasympatholytics; Pargyline; Prenylamine; Procyclidine; Rats; Reflex; Reserpine; Seizures; Tranylcypromine | 1968 |
Motor disturbance induced by tremorine and oxotremorine.
Topics: Acetylcholine; Amines; Animals; Atropine; Biperiden; Brain; Bridged-Ring Compounds; Chlorpromazine; Depression, Chemical; Dihydroxyphenylalanine; Electromyography; Ethanolamines; Motor Activity; Motor Neurons; Parasympatholytics; Parkinson Disease; Piperazines; Procaine; Propranolol; Pyrrolidines; Rats; Reflex; Spinal Nerves; Tremor; Tremorine; Vasodilator Agents | 1970 |
Investigations on the effect of some drugs on the Parkinsonian rigidity.
Topics: Adult; Atropine; Biperiden; Female; Humans; Injections, Intravenous; Male; Middle Aged; Muscle Contraction; Orphenadrine; Oscillometry; Parasympatholytics; Parkinson Disease; Procyclidine; Tropanes | 1970 |
[Modification of central mechanisms of action by anticholinergics].
Topics: Aggression; Amphetamine; Animals; Apomorphine; Atropine; Biperiden; Bridged-Ring Compounds; Central Nervous System; Chlorpromazine; Depression, Chemical; Drug Synergism; Esters; Female; Hexobarbital; Humans; Imipramine; Male; Mice; Morphine; Nicotine; Parasympatholytics; Pentylenetetrazole; Perphenazine; Rats; Stimulation, Chemical; Strychnine; Tremorine | 1969 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |
[Neurological aspects and modern trends in therapy of Parkinson's disease].
Topics: Atropine; Biperiden; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1980 |
Importance of cholinolytic drug selection for the efficacy of HI-6 against soman in rats.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Benactyzine; Biperiden; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Corticosterone; Diaphragm; Drug Interactions; Liver; Male; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman; Stress, Physiological; Tyrosine Transaminase | 1997 |
[The effect of parasympatholytics on the therapeutic effectiveness of the oxime HI-6 against organophosphorus compounds (Soman, substance VX, Fosdrin) in mice].
Topics: Animals; Antidotes; Atropine; Benactyzine; Biperiden; Cholinesterase Reactivators; Male; Mevinphos; Mice; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Parasympatholytics; Pyridinium Compounds; Soman | 1997 |
Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication.
Topics: Animals; Anticonvulsants; Atropine; Biperiden; Cholinesterase Inhibitors; Cholinesterase Reactivators; Disease Models, Animal; Drug Therapy, Combination; Electroencephalography; Guinea Pigs; Lethal Dose 50; Male; Organophosphates; Organophosphorus Compounds; Pralidoxime Compounds; Pyridostigmine Bromide; Sarin; Seizures; Soman | 2000 |
The influence of anticholinergic drug selection on the efficacy of antidotal treatment of soman-poisoned rats.
Topics: Animals; Antidotes; Atropine; Benactyzine; Biperiden; Blood Pressure; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Electrocardiography; Heart Rate; Male; Muscarinic Antagonists; Oximes; Pyridinium Compounds; Rats; Scopolamine; Soman | 2000 |